Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.000769230769230753 -0.000769230769230753 -0.000769230769230753 -0.000769230769230753
Stock impact report

Health Canada approval of new ALS drug allows Canadians to get access first [Toronto Globe and Mail (Ontario, Canada)]

Amylyx Pharmaceuticals, Inc. (AMLX) 
Health Canada has become the first regulator in the world to approve a new amyotrophic lateral sclerosis (ALS) drug, only the third therapy for treatment of the fatal motor neuron condition to be authorized in 20 years. Amylyx Pharmaceuticals, based in Massachusetts, announced the decision Monday, saying the approval was made with the condition the company will provide Health Canada with further evidence of the drug’s safety and efficacy once a larger trial is completed this summer. ALS patients and researchers celebrated the news, highlighting how few treatment options exist for those living with the disease, which progressively robs people of their ability to move, speak, swallow and breathe. “Anything that can slow the progression of this disease and allow people to retain their function longer is so significant,” said Tammy Moore, chief executive officer of the ALS Society of Canada. First person: Living with the uncertainty of ALS has taught me some valuable lessons Justin Kle Show less Read more
Impact Snapshot
Event Time:
AMLX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
AMLX alerts

from News Quantified
Opt-in for
AMLX alerts

from News Quantified